Cytek Biosciences (CTKB)

• Market cap: $502M
• 1 day: -2.24%
• 5 days: -4.85%
• 1 month: -8.84%
• 3 months: -40.33%
• 6 months: -27.27%
• Year to date: -40.33%
• 1 year: -41.49%
• 5 years: -79.10%
• 10 years: -79.10%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 16

30% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 43

20% more capital invested

Capital invested by funds: $419M [Q3] → $501M (+$82.6M) [Q4]

11% more funds holding

Funds holding: 136 [Q3] → 151 (+15) [Q4]

2.5% more ownership

Funds ownership: 57.45% [Q3] → 59.95% (+2.5%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $6 53% upside
• Avg. target: $7 79% upside
• High target: $8 104% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Stephens & Co. Mason Carrico 18% 1-year accuracy 5 / 28 met price target	53% upside $6	Overweight Reiterated	19 Mar 2025
Piper Sandler David Westenberg 44% 1-year accuracy 19 / 43 met price target	104% upside $8	Overweight Maintained	4 Mar 2025